Clinical Trial

Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma

Name: Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma — clinical trial record (NCT07126990)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 1/2

View on ClinicalTrials.gov →

Summary

Clinical study of a novel oncolytic virus Ad-TD-nsIL12 in the treatment of primary high-grade glioma

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-08-11; most recent amendment 2026-03-19.

Trial Details

NCT Number	NCT07126990
Lead Sponsor	Xiaorong Wu Collaborators: Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Conditions	Glioma
Enrollment	40 participants
Start Date	2025-02-12
Primary Completion	2028-08-30 (estimated)
Study Completion	2028-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-23